1. Stephen C Harbison, Giffe T Johnson, James D McCluskey, Ping Xu, Shelia Mohammad, Jay Wolfson, and Raymond D Harbison. 2012.Occupational Health Surveillance: Pulmonary Function Testing in Utility WorkersJ Clinic Toxicol 2012, S:5
2. McCluskey JD, Johnson GT, Harbison RD. (2012). Allergic Bronchopulmonary Aspergillosis (ABPA) in a Patient with severe Chronic Obstructive Pulmonary Disease: A Rare Case Report and Discussion of Risk Factors. Journal of Medicine (accepted/in press)
3. Johnson, G.T., Harbison S.C., McCluskey J.D., Xu P., Wolfson J., and Harbison R.D. (2012)Occupational health surveillance: Pulmonary function testing in boat manufacturer workers. Journal of Medicine 41:1-12.
4. Blake CL, Johnson GT, Abritis AJ, Lieckfield R Jr, Harbison RD. (2012)Isocyanate and VOC exposure analysis usingFlexane®. Regul Toxicol Pharmacol. 63(3):363-70
5. LeBeau AL, Johnson GT, McCluskey JD, Harbison RD (2012)Evaluation of Urinary Pesticide Biomarkers among a Sample of the Population in the United States. J Clinic Toxicol S5:003. doi:10.4172/2161-0495.S5-003
6. McCluskey JD, Sava D, Harbison SC, Muro-Cacho CA,Johnson G, Xu P, and Harbison RD. (2011)Hepatoprotective effects of select water soluble PARP inhibitors in a carbon tetrachloride model. International Journal of Critical Illness and Injury Science 1(2):97-103.
7. Smith CJ, Johnson GT, Harbison RD, Zhu Y, Lee RV, Banasik M, Stedeford T. (2011). Dose-dependent neurologic abnormalities in workers exposed to 1-bromopropane. J Occup Environ Med 53:707-8.
8. DeHate RB, Johnson GT, Harbison RD. (2011)Risk Characterization of Vapor Intrusion in Former Manufactured Gas Plant Sites. Regulatory Toxicology and Pharmacology 59:353-359
9. Hall KW, Muro-Cacho C, Abritis A, Johnson GT, Harbison RD. (2010). Attenuation of Bromobenzene-Induced Hepatotoxicity by Poly(ADP-Ribose) Polymerase Inhibitors. Research Communications in Molecular Pathology and Pharmacology. 122-123(1-6):79-96
10. Goodman JE, Kerper LE, Johnson GT, Harbison RD, Cordero R, Lee RV, Pulde MF, Hardy M, and Stedeford T. (2010)PBDE flame retardants and thyroid hormone during pregnancy. Environ Health Perspect, Vol. 118, p. A2 (doi: 10.1289/ehp.1002782).
11. Xu P, Wu Y, Zhu Y, Dagne G, Johnson G, Cuthbertson D, Krischer JP, Sosenko JM. (2010)Prognostic Performance of Metabolic Indexes in Predicting Onset of Type 1 Diabetes. Diabetes Care. 33:2508-2513
12. Goodman JE, Biesemeier JA, Johnson GT, Harbison C, Harbison RD, et al. (2010)Fecundability and Serum PBDE Concentrations in Women. Environ Health Perspect 118(8):a330.
13. Crane JS, McCluskey JD, Johnson GT, Harbison RD. (2010)Assessment of community healthcare providers ability and willingness to respond to emergencies resulting from bioterrorist attacks. J Emerg Trauma Shock 3:13-20.
14. Johnson GT, Zhu Y, and Harbison RD. (2010)Comment on: Effects of Decabrominated Diphenyl Ether (PBDE 209) Exposure at Different Developmental Periods on Synaptic Plasticity in the Dentate Gyrus of Adult Rats In Vivo.Toxicological Sciences 114(2):387–388
15. Johnson GT, Harbison SC, McCluskey JD, Harbison RD. (2009)Characterization of cancer risk from airborne benzene exposure. Regulatory Toxicology and Pharmacology. 2009. 55:361-366
16. Grivas PC, Muro-Cacho CA, Johnson GT, Abritis AJ, Harbison RD. (2009). A Novel Pharmacological Application for Aminophylline: Antagonism of Acute Chemical-Induced Hepatotoxicity. Journal of Medicine. 40(1):5-19
17. Khlifi M, Zun L, Johnson G, Harbison R. (2009)Etiological characterization of acute poisonings in the emergency department. J Emerg Trauma Shock 2:159-63
18. Blake CL, Johnson GT, Harbison RD. (2009)Airborne asbestos exposure during light aircraft brake replacement. Regulatory Toxicology and Pharmacology. 54:242–246
19. Scharf JE, Johnson G, Harbison SC, McCluskey JD, Harbison RD (2008)Dermal absorption of a dilute aqueous solution of malathion. Journal of Emergencies, Trauma, and Shock. 1:22-30
20. Francois MR, Johnson GT, Hoare IA, Wolfson J, Dziuban CD, Harbison RD. (2008)Predicting Return to Work in patients with Coronary Heart Disease. 39:43-52
21. Grivas P, Tanaka S, Ueda K, Johnson G, Harbison RD. (2007)6,(5H)-phenanthradinone protects against carbon tetrachloride-induced cytotoxicity in human HepG2 cells. Research Communications in Molecular Pathology and Pharmacology. 120(1-6):123-132
22. Francois MR, Grivas PC, Williams CR, Johnson GT, Studnicki J, Blair RC, Harbison RD. (2005) Predicting the Risk of Respiratory-Related Hospital Admissions Using an Air Pollution Model. Journal of Medicine (JOM) 36(1-6):5-25

Null